Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:30 AM
Ignite Modification Date:
2025-12-25 @ 4:30 AM
NCT ID:
NCT07092618
Eligibility Criteria:
Inclusion Criteria:
* Existing AgelessRx patient
* Adults (40 - 85 years of age)
* Any sex
* Any ethnicity
* BMI ≥ 22 kg/m\^2
* Have been on GLP-1s (Wegovy, Ozempic, or a compounded form of GLP-1s) for at least three months before study initiation
* Have lost at least 15 lbs during their GLP-1 use
Exclusion Criteria:
* Individuals who are denied a longevity product by the AgelessRx medical team will not be asked to participate in any product specific test(s) or questionnaire(s)
* History of bariatric surgery
* Use of weight-loss medications other than GLP-1s within the past 6 months
* Age \<40 years
* Contraindications to naltrexone, metformin, or rapamycin
* Significant psychiatric illness that may affect participation
* Pregnant or breastfeeding individuals
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
85 Years
Study:
NCT07092618
Study Brief:
Protocol Section:
NCT07092618